Clinical guideline for male lower urinary tract symptoms
Authors:
Open Access
- 6 October 2009
- journal article
- practice guideline
- Published by Wiley in International Journal of Urology
- Vol. 16 (10) , 775-790
Abstract
Abstract: This article is a shortened version of the clinical guideline for lower urinary tract symptoms (LUTS), which has been developed in Japan for symptomatic men aged 50 years and over irrespective of presumed diagnoses. The guideline was formed on the PubMed database between 1995 and 2007 and other relevant sources. The causes of male LUTS are diverse and attributable to diseases/dysfunctions of the lower urinary tract, prostate, nervous system, and other organ systems, with benign prostatic hyperplasia, bladder dysfunction, polyuria, and their combination being most common. The mandatory assessment should comprise medical history, physical examination, urinalysis, and measurement of serum prostate‐specific antigen. Symptom and quality of life questionnaires, bladder diary, residual urine measurement, urine cytology, urine culture, measurement of serum creatinine, and urinary tract ultrasonography would be optional tests. The Core Lower Urinary Tract Symptom Score Questionnaire may be useful in quickly capturing important symptoms. Severe symptoms, pain symptoms, and other clinical problems would indicate urological referral. One should be careful not to overlook underlying diseases such as infection or malignancy. The treatment should be initiated with conservative therapy and/or medicine such as α1‐blockers. Treatment with anticholinergic agents should be reserved only for urologists, considering the risk of urinary retention. The present guideline should help urologists and especially non‐urologists treat men with LUTS.Keywords
This publication has 116 references indexed in Scilit:
- The Association Between Vascular Risk Factors and Lower Urinary Tract Symptoms in Both SexesEuropean Urology, 2006
- Health education on self-management and seeking health care in older adults: a randomised trialPatient Education and Counseling, 2004
- Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladderBJU International, 2004
- Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2004
- ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinenceNeurourology and Urodynamics, 2004
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Age Related Urodynamic Changes in Patients with Benign Prostatic HyperplasiaJournal of Urology, 1996
- The norepinephrine tissue concentration and neuropeptide Y immunoreactivity in genitourinary organs of the spontaneously hypertensive ratJournal of the Autonomic Nervous System, 1996
- Tamsulosin, a selective α 1c ‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic HyperplasiaNew England Journal of Medicine, 1995